Search Results

Kathryn obtained her BS in Chemistry from Carnegie Mellon University and went on to receive a Ph.D. in Pharmacology

Pfleger trained as a pharmacologist and obtained his Ph.D. at the University of Edinburgh. I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the He is Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research and Harry He currently serves on the Board of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and is a member of the British Pharmacological Society International Advisory Group

Tall joined the faculty in the Department of Pharmacology and Physiology at the University of Rochester Tall moved to the University of Michigan in 2016 as an Associate Professor of Pharmacology and is a current

screening compounds, or designing next-gen molecules, this insight reframes what “success” in computational pharmacology

Work in his independent laboratory is focused on developing new pharmacological tools via chemistry and

Patrick Sexton Patrick Sexton is a Professor of Pharmacology, National Health and Medical Research Council He is a 2021 Clarivate Analytics Highly Cited Researcher in two disciplines: Pharmacology & Toxicology and Biology & Biochemistry, a corresponding member of the International Union of Basic and Clinical Pharmacology division) and an elected Fellow of the British Pharmacological Society (BPS). Sexton’s awards include the Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists

Centre de Recherche du Centre Hospitalier de l'Université de Montréal; Faculté de Pharmacie. 900 St-Denis About John Stagg "John Stagg is a Professor of Pharmacy at Université de Montréal and researcher at the

Join us to learn more about chemosensory GPCRs and how computational pharmacology can help better understand

contingency-ready paths " Yamina brings scientific clarity, leadership, and precision execution to complex pharmacological Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution

Steven Foord Steve Foord trained as a Physiologist and Pharmacologist and worked for Glaxo through to He introduced molecular pharmacology to a wide range of the company's GPCR projects and was able to initiate

David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD in Molecular Pharmacology & Drug Discovery. In 2014 David joined the University of Nottingham and began a part-time PhD in Molecular Pharmacology

Caron is also past Associate Editor at JCI and served as the inaugural Associate Editor at ACS-Pharmacology Lauren Slosky "Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member She received a Ph.D. in Medical Pharmacology from The University of Arizona in 2015 and completed a postdoctoral Integrating GPCR biology, behavioral pharmacology, and systems neuroscience approaches, the Slosky Lab She is currently a faculty trainer for the University of Minnesota's MS and Ph.D. programs in Pharmacology

using innovative approaches, including biosensors, cryo-EM, photoswitchable ligands, and nanobodies as pharmacological

Elva Zhao About this episode Elva is currently a research fellow at the Monash Institute of Pharmaceutical

She has expertise in cell biology, pharmacology, translational medicine, oncology, immuno-oncology, immunology Previously, she held the position of Vice President of Cell Biology & Pharmacology, at Bristol-Myers

Mark Connor Undergraduate BSc with Honours in Pharmacology from University of Sydney (1987, snake neurotoxins ), Ph.D. from Department of Pharmacology, University of Washington (1992, mentor Charley Chavkin , sigma and T-type Ca channels) and Brain and Mind Research Institute (Sydney). 2009, appointed Professor of Pharmacology Currently pursuing molecular pharmacology of phytocannabinoids and novel synthetic cannabinoids, with

Philip Seeman in the Department of Pharmacology at the University of Toronto. He later joined the laboratory of eminent biochemical pharmacologist, Dr. Alfred G. His training has provided a strong foundation and appreciation for the applications of pharmacology, In 2015 Professor Sunahara moved his laboratory to the Department of Pharmacology at the University of The Sunahara lab utilizes biochemical, biophysical and pharmacological methodologies to study GPCR-G

Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology in the same university that was conferred in 2009. He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards Maddi is currently a second year Ph.D. student in the Molecular Pharmacology and Therapeutics (MPaT)

Explore Terry’s Pharmacology Vault. Published on October 27, 2025 Category Terry's Corner Receptor pharmacology has evolved. These lessons bridge molecular pharmacology with real-world design strategy, giving discovery teams the GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #DrugDiscovery #Kinetics #ReceptorPharmacology #MedicinalChemistry

Paul Insel is currently a Distinguished Professor of Pharmacology and the University of California San scientific journals, including but not limited to the Journal of Clinical Investigation, Molecular Pharmacology , British Journal of Pharmacology, and American Journal of Physiology-Cell Physiology.

She earned her M.Sc. in Zoology and Neurobiology before completing a Ph.D. in Biology and Pharmacology

Peptide-Based Therapeutics Summit - USA April 2 - 3, 2025 | New therapeutic modalities: Transforming receptor pharmacology June 22 - 26, 2025 | G Protein-coupled Receptor Kinases and Arrestins - USA December 16 - 18, 2025 |Pharmacology 2025 - UK July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology - Australia GPCR Company Postdoctoral Posit ion And PhD Position - Autonomous University of Barcelona GPCR Molecular Pharmacologist

During these four sessions, you'll dive into: Advanced pharmacokinetic modeling The Druglike Quality discovery Symposium & Workshop NEW April 2 - 3, 2025 | New therapeutic modalities: Transforming receptor pharmacology Summit June 22 - 26, 2025 | G Protein-coupled Receptor Kinases and Arrestins NEW December 16 - 18, 2025 |Pharmacology 2025 July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Structural associate position and a PhD/post-doc level position Postdoctoral Position And PhD Position GPCR Molecular Pharmacologist

Terry Kenakin , a leading expert in pharmacology, as he unpacks the fascinating world of signaling bias Kenakin will explain that bias is not an exception but a fundamental principle of pharmacology, occurring Don't miss this opportunity to refine your understanding of bias as a tool, not an obstacle, in pharmacology Key Highlights 🔍 Bias is Everywhere : Signaling bias naturally occurs in pharmacology—whether we look industry professional, this session is packed with insights that will make you rethink your approach to pharmacology